首页> 美国卫生研究院文献>other >Comparison of Patients from Nigeria and the USA Highlights Modifiable Risk Factors for Sickle Cell Anemia Complications
【2h】

Comparison of Patients from Nigeria and the USA Highlights Modifiable Risk Factors for Sickle Cell Anemia Complications

机译:尼日利亚和美国患者的比较突出显示镰状细胞性贫血并发症的可改变危险因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To identify factors that affect manifestations of sickle cell anemia we compared patients 11-30 years of age from University of Ibadan, Nigeria (n = 214) and University of Illinois at Chicago, USA (n = 209). Paralleling findings in the general populations of the two countries, the Chicago patients were more often overweight or obese as defined by the Centers for Disease Control (Atlanta, GA, USA) guidelines, and more often had elevated blood pressure (BP) as defined by the National Heart, Lung, and Blood Institute (Bethesda, MD, USA) guidelines. The Ibadan sickle cell anemia patients less frequently received the pneumococcal vaccine or hydroxyurea (HU) therapy. Consistent with lower rates of elevated BP and increased body mass index (BMI), stroke history was less frequent in the Ibadan patients ≥18 years old. Furthermore, in combined analyses, systolic and diastolic BP directly correlated with BMI, and elevated weight status independently associated with history of stroke [odds ratio (OR) 2.7, p = 0.019]. Our findings are consistent with the possibility that higher values for BMI and BP in Chicago sickle cell anemia patients may contribute to an increased risk of stroke and highlights the need for measures to reduce these risk factors. On the other hand, lower pneumococcal vaccination and HU therapy rates in Ibadan patients highlights the need for more improved vaccination coverage and for studies to define the role of HU therapy in Africa.
机译:为了确定影响镰状细胞性贫血表现的因素,我们比较了尼日利亚伊巴丹大学(n = 214)和美国芝加哥伊利诺伊大学(n = 209)的11-30岁患者。在这两个国家的普通人群中发现的结果相似,根据疾病控制中心(Atlanta,GA,USA)指南的定义,芝加哥患者更经常超重或肥胖,而根据以下定义,其血压升高(BP)则更常见国家心脏,肺和血液研究所(美国马里兰州贝塞斯达)的指南。伊巴丹镰刀型贫血患者较少接受肺炎球菌疫苗或羟基脲(HU)治疗。与较低的血压升高率和体重指数(BMI)升高相一致,≥18岁的伊巴丹患者中风史较少。此外,在综合分析中,收缩压和舒张压与BMI直接相关,体重增加与卒中史无关[比值比(OR)2.7,p = 0.019]。我们的发现与芝加哥镰状细胞性贫血患者较高的BMI和BP值可能会增加中风风险的可能性相吻合,并强调需要采取措施减少这些危险因素。另一方面,伊巴丹患者的肺炎球菌疫苗接种率和HU治疗率较低,这凸显了需要进一步提高疫苗接种覆盖率和进行研究以确定HU治疗在非洲的作用的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号